Research Reports
+ Policy Briefs

COVID-19 Global Trends and Analyses Volume 2:- Vaccine and Viral Variants Update - COVID-19 Global Snapshots. (PUBLIC HEALTH REPORT)

Covid-19 Global Trends and Analysis - Volume 2: SARS-CoV-2 viral load dynamics and infectivity.

Covid-19 Global Trends and Analysis - Global Epidemiology and Global Snapshots. (PUBLIC HEALTH REPORT)

Estimating risks associated with early reopening in Victoria. (Policy Brief prepared for the Victorian Department of Health and Human Services)

Improving general practitioners' knowledge of hepatitis C care

General practitioners' knowledge of hepatitis C care has increased over time, yet many are unsure wh...

Direct-acting antivirals have increased the number of people being cured of hepatitis C.

The number of people being cured of hepatitis C has improved since the introduction of direct-acting...

The most promising vaccines for COVID-19. (Updated 17.6.2020)

There are currently 11 vaccine candidates for COVID‑19 in clinical trials. Five of the six vaccines ...

World-first study shows the benefits of treating hepatitis C in primary care

Providing hepatitis C treatment in the primary care setting increases both treatment uptake and cure...

A successful pilot of point-of-care hepatitis C testing at community needle and syringe programs

Rapid EC: Point-of-care testing for hepatitis C at needle and syringe programs is feasible and accep...

Hepatitis C elimination requires more than universal availability of treatment

Universal availability of hepatitis C treatment is a critical but insufficient step towards eliminat...

Collaborative approach in primary care increases access to hepatitis C treatment in a regional area

Implementation of a remote consultation pathway facilitates interaction between general practitioner...

Identifying high-priority regions for hepatitis C treatment in Australia

Targeted interventions are needed to increase hepatitis C treatment uptake in non- metropolitan area...

Eliminating hepatitis C virus among HIV-positive men

Routine testing and prompt treatment uptake can significantly reduce hepatitis C prevalence among HI...

Elimination of hepatitis C requires a comprehensive approach to care

Universal access to hepatitis C medication alone is insufficient to eliminate hepatitis C as a publi...

Resources are required to support management of hepatitis C in general practice

A Burnet Institute survey undertaken in 2016 showed that although many general practitioners are int...

Needle sharing remains the major risk factor for hepatitis C infection

Hepatitis C incidence appears to be decreasing, but in a cohort of people who inject drugs in Melbou...

Psychological distress in people who inject drugs

People who inject drugs experience high levels of psychological distress and recent assault, intenti...

Evidence supports community-based hepatitis C care

A systematic review conducted in 2015 demonstrated that – compared to tertiary- based hepatitis C ca...

Achievable and cost-effective elimination targets in Australia

Reaching the WHO hepatitis C elimination targets in Australia is cost-effective and can be achieved ...

Treating hepatitis C saves lives and is cost-effective

Treating people who inject drugs for hepatitis C with new therapies is cost-effective and could prev...